Han Ying
Technik-/Wissenschafts-/F&E-Leiter bei IMMUNOTECH BIOPHARM LTD
Profil
Han Ying is the founder of Gene Corp., which was founded in 2021.
Dr. Ying is currently the Chief Executive Officer & Director at Gyre Therapeutics, Inc. since 2023 and the Chief Scientific Officer at Immunotech Biopharm Ltd.
Dr. Ying previously worked as a Director at Base Therapeutics.
Dr. Ying obtained a doctorate degree from Stanford University and completed undergraduate and graduate degrees from Peking University.
Aktive Positionen von Han Ying
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOTECH BIOPHARM LTD | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Han Ying
| Unternehmen | Position | Ende |
|---|---|---|
Gene Corp.
 Gene Corp. Specialty StoresRetail Trade Part of East Japan Railway Co., Gene Corp. operates sundry goods stores. The company is based in Setagaya-ku, Japan. Gene was acquired by Lumine Co., Ltd. on September 07, 2004. | Gründer | - |
Ausbildung von Han Ying
| Stanford University | Doctorate Degree |
| Peking University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMMUNOTECH BIOPHARM LTD | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Gene Corp.
Gene Corp. Specialty StoresRetail Trade Part of East Japan Railway Co., Gene Corp. operates sundry goods stores. The company is based in Setagaya-ku, Japan. Gene was acquired by Lumine Co., Ltd. on September 07, 2004. | Retail Trade |
